OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
OrthoPediatrics Corp. (Nasdaq: KIDS), a company dedicated to advancing pediatric orthopedics, has announced its schedule for releasing second quarter 2024 financial results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS), a company dedicated to advancing pediatric orthopedics, has announced its schedule for releasing second quarter 2024 financial results. The company will unveil its financial performance on Monday, August 5, 2024, after the market closes. Following this, OrthoPediatrics will host a conference call on Tuesday, August 6, 2024, at 8:00 a.m. ET to discuss the results in detail.
Investors interested in the call can access a live and archived webcast of the event through the company's website at www.orthopediatrics.com, specifically on the Investors page in the Events & Presentations section. The webcast will remain available for replay for at least 90 days after the event, providing ample opportunity for stakeholders to review the information.
Details
News Market Reaction – KIDS
The recorded move for KIDS in the trading session of this news was +1.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 6, 2024, at 8:00 a.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 71 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.